Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

mizolastine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Like any other drugs, antiallergic medications can be associated with large inter- and intraindividual variability in their… Expand
Review
2008
Review
2008
The use of antihistamines (AHs) has been associated with cognitive and psychomotor impairments, largely caused by the sedative… Expand
Review
2006
Review
2006
Levocetirizine (Xyzal) is a selective, potent, oral histamine H(1) receptor antagonist of the latest generation that is licensed… Expand
  • figure 1
  • table I
  • table II
  • table III
  • table IV
Review
2004
Review
2004
Absorption, distribution, metabolism and excretion of desloratadine, fexofenadine, levocetirizine, and mizolastine in humans have… Expand
Highly Cited
2002
Highly Cited
2002
BACKGROUND Levocetirizine is the active enantiomer of cetirizine, a potent drug with little metabolism widely used for allergic… Expand
2002
2002
Background Mizolastine is a potent and selective H1‐receptor antagonist with antiallergic properties; in in‐vitro animal models… Expand
Highly Cited
1999
Highly Cited
1999
Urticaria is one of the most common and, in its chronic course, excruciating dermato‐allergic diseases. Apart from the… Expand
Review
1999
Review
1999
  • Y. G. Yap, A. Camm
  • Clinical and experimental allergy : journal of…
  • 1999
  • Corpus ID: 34802061
Antihistamines (H1‐receptor antagonists) are amongst the most frequently prescribed drugs worldwide for the treatment of allergic… Expand
Highly Cited
1996
Highly Cited
1996
A two‐centre, double‐blind, randomized, placebo (P)‐controlled, parallel‐group study was conducted in the UK to examine the… Expand
Review
1995
Review
1995
The review summarizes the major results of eight double‐blind, placebo‐controlled, volunteer studies undertaken by three… Expand